Dermatology Drugs Market [(By Therapeutic Area (Atopic Dermatitis, Psoriasis, Acne, Rosacea), By Marketed Therapies (Biologics, Oral Drugs, Topical Drugs), By Approved Treatments (etanercept (Enbrel), infliximab (Remicade), adalimumab (Humira), ustekinumab (Stelara), secukinumab (Cosentyx), ixekizumab (Taltz), golimumab (Simponi), brodalumab (Siliq), and guselkamab (Tremfya), and By Region]: Market Size & Forecast, 2017 – 2022
- Published Date: Feb 2018
- Pages: 75
- Format: PDF
- Report ID: PM1106
- Base Year: 2016
- Historical Data: 2015-2016
Request for Discount Pricing
Please fill out the form and get quote for your specific research needs
License and Pricing
Purchase Report Sections
- Regional analysis
- Segmentation analysis
- Industry outlook
- Competitive landscape
Connect With Experts
Suggested Report
- Non-Invasive Prenatal Testing (NIPT) Market Share, Size, Trends, Industry Analysis Report, 2021 - 2028
- PET-CT Scanner Device Market Share, Size, Trends, Industry Analysis Report, 2021 - 2028
- Primary Cells Market Share, Size, Trends, Industry Analysis Report, 2021 - 2028
- 皮下的避孕Implants Market Share, Size, Trends, Industry Analysis Report, 2021 - 2028
- Nuclear Medicine Market Share, Size, Trends, Industry Analysis Report, 2021 - 2028
Global Dermatology Drugs Market Size & Share - Industry Report, 2022